Marcel Smid

Marcel Smid

UNVERIFIED PROFILE

Are you Marcel Smid?   Register this Author

Register author
Marcel Smid

Marcel Smid

Publications by authors named "Marcel Smid"

Are you Marcel Smid?   Register this Author

99Publications

3007Reads

26Profile Views

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer.

Sci Rep 2019 Sep 16;9(1):13308. Epub 2019 Sep 16.

Division of Drug Discovery and Safety, Leiden Academic Center for Drug Research, Leiden University, PO box 9502, 2300, RA, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-49809-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746778PMC
September 2019

Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.

Breast Cancer Res 2019 09 18;21(1):109. Epub 2019 Sep 18.

Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Einthovenweg 20, 2333 ZC, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
https://breast-cancer-research.biomedcentral.com/articles/10
Publisher Site
http://dx.doi.org/10.1186/s13058-019-1194-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751614PMC
September 2019

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.

Int J Cancer 2019 Aug 27;145(4):1083-1089. Epub 2019 Feb 27.

Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32209DOI Listing
August 2019

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy.

Breast Cancer Res 2019 07 1;21(1):77. Epub 2019 Jul 1.

Department of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, 2300 RA, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-019-1161-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604188PMC
July 2019

Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancer.

Biomark Med 2019 Jul 18;13(10):841-850. Epub 2019 Jul 18.

Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm-2019-0050DOI Listing
July 2019

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines.

PLoS One 2019 7;14(5):e0216400. Epub 2019 May 7.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0216400PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504094PMC
May 2019

Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.

Eur J Surg Oncol 2019 04 18;45(4):691-698. Epub 2018 Oct 18.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus Medical Center Rotterdam, the Netherlands. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07487983183143
Publisher Site
http://dx.doi.org/10.1016/j.ejso.2018.09.019DOI Listing
April 2019

Co-regulated gene expression of splicing factors as drivers of cancer progression.

Sci Rep 2019 Apr 2;9(1):5484. Epub 2019 Apr 2.

Division of Drug Discovery and Safety, LACDR, Leiden University, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-40759-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445126PMC
April 2019

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2019 02;566(7742):E1

Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41586-019-0883-2
Publisher Site
http://dx.doi.org/10.1038/s41586-019-0883-2DOI Listing
February 2019

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers.

Cancers (Basel) 2018 Dec 9;10(12). Epub 2018 Dec 9.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers10120500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318759PMC
December 2018

Epithelial-Mesenchymal Transition in Human Prostate Cancer Demonstrates Enhanced Immune Evasion Marked by IDO1 Expression.

Cancer Res 2018 08 19;78(16):4671-4679. Epub 2018 Jun 19.

Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-3752DOI Listing
August 2018

Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer.

Clin Cancer Res 2018 07 16;24(14):3397-3408. Epub 2018 Apr 16.

Department of Radiation Oncology, Radiotherapy and OncoImmunology Laboratory, Radboud university medical center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-2551DOI Listing
July 2018

The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.

Neuroendocrinology 2017 26;105(4):384-393. Epub 2017 Jan 26.

Department of Pathology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000455864DOI Listing
June 2018

Identification of microRNA biomarkers for response of advanced soft tissue sarcomas to eribulin: Translational results of the EORTC 62052 trial.

Eur J Cancer 2017 04 16;75:33-40. Epub 2017 Feb 16.

Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.12.018DOI Listing
April 2017

Predicting paclitaxel-induced neutropenia using the DMET platform.

Pharmacogenomics 2015 12;16(11):1231-41. Epub 2015 Aug 12.

Department of Clinical Chemistry, Erasmus University Medical Center, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.68DOI Listing
June 2016

Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Nature 2016 06 2;534(7605):47-54. Epub 2016 May 2.

Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature17676DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910866PMC
June 2016

The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies.

Proteomics 2016 05 28;16(10):1474-85. Epub 2016 Apr 28.

Department of Medical Oncology, Erasmus University Medical Center - Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.201600004DOI Listing
May 2016

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.

Oncotarget 2016 May;7(20):29166-76

Department of Medical Oncology and Cancer Genomics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045386PMC
May 2016

An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma.

Am J Surg Pathol 2016 Apr;40(4):569-76

Departments of *Pathology ∥Bioinformatics ¶¶¶Medical Oncology ∥∥∥Internal Medicine, Division of Endocrinology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam ††Laboratory for Pathology, PAL Dordrecht, Dordrecht ###Department of Pathology, Reinier de Graaf Hospital, Delft ****Department of Pathology, University Medical Center Utrecht, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands †Department of Histopathology, King's College Hospital, London ***Department of Pathology, University Hospitals Birmingham, Birmingham †††Department of Histopathology, Royal Hallamshire Hospital, Sheffield, UK ‡Department of Clinical and Molecular Medicine, Pathology Unit, Sant' Andrea Hospital, Sapienza University, Rome ¶Department of Oncology, University of Turin at San Luigi Hospital, Orbassano, Italy §Department of Pathology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI #Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI **Department of Pathology and Laboratory Medicine, Tufts Medical Center, Tufts University School of Medicine ‡‡Department of Pathology, Massachusetts General Hospital, Boston, MA §§Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN ∥∥Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada ¶¶Department of Anatomical Pathology, Royal North Shore Hospital and University of Sydney, Sydney, NSW, Australia ##Department of Pathology and Molecular Genetics and Research Laboratory, Hospital Universitari Arnau de Vilanova, IRBLLEIDA, University of Lleida, Lleida, Spain ‡‡‡INSERM U1016 CNRS UMR8104, Institut Cochin, Paris Descartes University, Sorbonne Paris Cité §§§Department of Pathology, Pitié-Salpetrière Hospital, APHP, Pierre and Marie Curie Univers

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000574DOI Listing
April 2016

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Mol Oncol 2016 Jan 7;10(1):24-39. Epub 2015 Aug 7.

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528925PMC
January 2016

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines.

BMC Cancer 2016 Jan 22;16:34. Epub 2016 Jan 22.

Faculty of Health and Medical Sciences, Department of Veterinary Disease Biology, Section for Molecular Disease Biology and Sino-Danish Breast Cancer Research Centre, University of Copenhagen, Strandboulevarden 49, DK-2100, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2071-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722663PMC
January 2016

PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.

Acta Neuropathol Commun 2015 Dec 23;3:88. Epub 2015 Dec 23.

Department of Neurology, Erasmus MC, Room Be 430A, POBox 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-015-0265-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690424PMC
December 2015

Global proteomic characterization of microdissected estrogen receptor positive breast tumors.

Data Brief 2015 Dec 8;5:399-402. Epub 2015 Oct 8.

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dib.2015.09.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773412PMC
December 2015

Understanding drugs in breast cancer through drug sensitivity screening.

Springerplus 2015 15;4:611. Epub 2015 Oct 15.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Postbus 2040, 's-Gravendijkwal 230, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-015-1406-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628005PMC
November 2015

mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Mol Oncol 2015 Apr 21;9(4):920-32. Epub 2015 Jan 21.

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528769PMC
April 2015

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

J Proteome Res 2015 Mar 2;14(3):1627-36. Epub 2015 Feb 2.

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam , Be401, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jproteome.5b00046DOI Listing
March 2015

Prognostic relevance of acquired uniparental disomy in serous ovarian cancer.

Mol Cancer 2015 Feb 3;14:29. Epub 2015 Feb 3.

Departments of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-015-0289-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320828PMC
February 2015

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells.

Breast Cancer Res Treat 2015 Feb 8;149(3):693-703. Epub 2015 Feb 8.

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6500 HB, Nijmegen, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3281-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326655PMC
February 2015

Response.

J Natl Cancer Inst 2014 Sep 29;106(9). Epub 2014 Sep 29.

: Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 CE Rotterdam, the Netherlands. *Current affiliation: Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, 6525 GA, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju254DOI Listing
September 2014

Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: application in breast cancer.

J Proteome Res 2014 Jun 14;13(6):2897-909. Epub 2014 May 14.

Department of Laboratory Medicine and Pathobiology, University of Toronto , 1 King's College Circle, Toronto, ON M5S 1A8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr500352eDOI Listing
June 2014

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.

J Natl Cancer Inst 2014 Feb 7;106(2):djt376. Epub 2014 Jan 7.

Affiliations of authors: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands (NQL, MPL, MS, RBHB, TDM, AMS, JWMM, JAF, AU); Department of Neurology (CS, TML) and Postgraduate School of Molecular Medicine (NQL, RBHB, TDM, AMS, JWMM, JAF, AU), Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Radiation Oncology (PNS) and Department of Laboratory Medicine (FCGJS), Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden (BKL); Department of Oncology/Pathology, Karolinska Institute, Stockholm, Sweden (BKL); Clinical Experimental Oncology Laboratory, National Cancer Centre Giovanni Paolo II, Bari, Italy (AM, AP); Translational Cancer Research Unit, Oncology Center, GZA Hospitals St-Augustinus, Antwerp, Belgium (LYD, SJVL); Netherlands Proteomics Centre, Utrecht, The Netherlands (NQL, AU); Cancer Genomics Centre, Utrecht, The Netherlands (MS, AMS, JWMM, JAF, AU); Center for Translational Molecular Medicine, Eindhoven, The Netherlands (RBHB, JAF, AU).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/early/2014/01/06/jnci
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/djt376
Publisher Site
http://dx.doi.org/10.1093/jnci/djt376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952199PMC
February 2014

A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platform.

Clin Cancer Res 2013 Sep 5;19(18):5210-7. Epub 2013 Aug 5.

Authors' Affiliations: Departments of Medical Oncology, Clinical Chemistry, and Trials and Statistics, Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, Tennessee; and Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0487DOI Listing
September 2013

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Cell 2013 Aug;154(5):1060-1073

Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 21205, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2013.07.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974915PMC
August 2013

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

Breast Cancer Res Treat 2013 Feb 22;138(1):47-57. Epub 2013 Jan 22.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-013-2415-3DOI Listing
February 2013

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.

Cancer Lett 2012 Jun 24;319(1):49-55. Epub 2011 Dec 24.

Erasmus MC, Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2011.12.031DOI Listing
June 2012

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.

Breast Cancer Res Treat 2012 Apr 26;132(2):439-48. Epub 2011 May 26.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1588-xDOI Listing
April 2012

Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer.

Breast Cancer Res Treat 2012 Feb 21;132(1):189-96. Epub 2011 May 21.

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Unit 1340, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-011-1579
Web Search
http://link.springer.com/10.1007/s10549-011-1579-y
Publisher Site
http://dx.doi.org/10.1007/s10549-011-1579-yDOI Listing
February 2012

Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.

Breast Cancer Res Treat 2011 Jul 15;128(1):23-30. Epub 2010 Jul 15.

Department of Medical Oncology, Josephine Nefkens Institute, Erasmus MC, DR, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-010-1026-5
Publisher Site
http://dx.doi.org/10.1007/s10549-010-1026-5DOI Listing
July 2011

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.

Breast Cancer Res Treat 2011 May 19;127(1):43-51. Epub 2010 May 19.

Department of Medical Oncology, Erasmus Medical Center Rotterdam, Josephine Nefkens Institute and Cancer Genomics Centre, Dr. Molewaterplein 50, Be 4.02 (lab)/4.35b (office), PO Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0940-xDOI Listing
May 2011

Association between acquired uniparental disomy and homozygous mutations and HER2/ER/PR status in breast cancer.

PLoS One 2010 Nov 30;5(11):e15094. Epub 2010 Nov 30.

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0015094PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994899PMC
November 2010

Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.

Gynecol Oncol 2010 May 4;117(2):170-6. Epub 2010 Feb 4.

Department of Medical Oncology, Erasmus MC-JNI-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.01.010DOI Listing
May 2010

Copy number alterations that predict metastatic capability of human breast cancer.

Cancer Res 2009 May 31;69(9):3795-801. Epub 2009 Mar 31.

Veridex LLC, a Johnson & Johnson Company, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4596DOI Listing
May 2009

Functional identification of genes causing estrogen independence of human breast cancer cells.

Breast Cancer Res Treat 2009 Mar 21;114(1):23-30. Epub 2008 Mar 21.

Department of Pathology, Josephine Nefkens Institute, Be 432, Erasmus MC-University Medical Center Rotterdam, P.O. Box 2040, Rotterdam, CA, 3000, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-008-9969-5
Publisher Site
http://dx.doi.org/10.1007/s10549-008-9969-5DOI Listing
March 2009

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.

J Clin Oncol 2009 Feb 15;27(4):542-9. Epub 2008 Dec 15.

Department of Pathology, Cancer Genomics Center, Josephine Nefkens Institute, Erasmus MC-University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.1462DOI Listing
February 2009

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.

Proc Natl Acad Sci U S A 2008 Sep 28;105(35):13021-6. Epub 2008 Aug 28.

Department of Medical Oncology, Erasmus Medical Center Rotterdam, Josephine Nefkens Institute, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0803304105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529088PMC
September 2008

Subtypes of breast cancer show preferential site of relapse.

Cancer Res 2008 May;68(9):3108-14

Department of Medical Oncology, Erasmus MC, Josephine Nefkens Institute, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-5644DOI Listing
May 2008

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer.

BMC Cancer 2007 Sep 25;7:182. Epub 2007 Sep 25.

Veridex LLC, a Johnson & Johnson Company, 3210 Merryfield Row, San Diego, CA 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-7-182DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077336PMC
September 2007

Genes associated with breast cancer metastatic to bone.

J Clin Oncol 2006 May 24;24(15):2261-7. Epub 2006 Apr 24.

Department of Medical Oncology, Erasmus MC-Daniel den Hoed, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.8802DOI Listing
May 2006

Storing, linking, and mining microarray databases using SRS.

BMC Bioinformatics 2005 Jul 27;6:192. Epub 2005 Jul 27.

Department of Urology, Josephine Nefkens Institute, Erasmus MC, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-6-192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1187877PMC
July 2005

GO-Mapper: functional analysis of gene expression data using the expression level as a score to evaluate Gene Ontology terms.

Bioinformatics 2004 Nov 6;20(16):2618-25. Epub 2004 May 6.

Department of Pathology, Josephine Nefkens Institute, Erasmus MC, P.O. Box 1738, 3000DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://academic.oup.com/bioinformatics/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/bioinformatics/bth293DOI Listing
November 2004

Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes.

Bioinformatics 2003 Nov;19(16):2065-71

Department of Pathology, Josephine Nefkens Institute, Erasmus MC, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btg282DOI Listing
November 2003